Literature DB >> 8054213

Differential effect of medium potent nonhalogenated double-ester-type and conventional glucocorticoids on proliferation and chemotaxis of fibroblasts in vitro.

R Hein1, H C Korting, T Mehring.   

Abstract

Recently several attempts have been made to develop glucocorticoids which show less pronounced side effects. We intended, therefore, to use experimental systems to examine the influence of newly developed nonhalogenated glucocorticoids and conventional fluorinated congeners, demonstrating similar anti-inflammatory activity in vivo, on biosynthetic capacities of human fibroblasts. Fibroblasts were kept in monolayer cultures and exposed to different concentrations of the active compounds for 6 days to analyze the influence on proliferation. Chemotaxis of fibroblasts was studied in blind well Boyden chambers. Fibroblast-conditioned medium was used as chemoattractant. All glucocorticoids tested influenced fibroblast proliferation at high (10(-5) M) and low (10(-9) M) concentration. Yet the effect was clearly more marked with fluorinated compounds. Basically, the same applied for chemotaxis. At the low concentration, however, nonfluorinated glucocorticoids exerted almost no influence. These results suggest that modifications of steroidal structure can specifically influence their effects on biosynthetic capacities of fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054213     DOI: 10.1159/000211309

Source DB:  PubMed          Journal:  Skin Pharmacol        ISSN: 1011-0283


  5 in total

1.  Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.

Authors:  A Gysler; K Lange; H C Korting; M Schäfer-Korting
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

2.  Synergistic action of endothelin (ET)-1 on the activation of bronchial fibroblast isolated from normal and asthmatic subjects.

Authors:  J Dubé; J Chakir; C Dubé; Y Grimard; M Laviolette; L P Boulet
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 3.  Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.

Authors:  M Schäfer-Korting; M H Schmid; H C Korting
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

4.  Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy.

Authors:  Hanne Norsgaard; Sandrine Kurdykowski; Pascal Descargues; Tatiana Gonzalez; Troels Marstrand; Georg Dünstl; Mads Røpke
Journal:  Arch Dermatol Res       Date:  2014-07-16       Impact factor: 3.017

5.  Pilot parallel randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people: 'STOPCUTS'.

Authors:  Roy J Powell; Christopher J Hayward; Caroline L Snelgrove; Kathleen Polverino; Linda Park; Rohan Chauhan; Philip H Evans; Rachel Byford; Carolyn Charman; Christopher J W Foy; Colin Pritchard; Andrew Kingsley
Journal:  Pilot Feasibility Stud       Date:  2017-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.